In the long battle against HIV, elite controllers have been held in awe.  They’re people who are HIV positive but maintain undetectable viral loads—they keep HIV in check without meds.  Researchers have tried and failed to engineer immune cells that would recognize and…

3 Congolese doctors have been arrested for planning attacks on Ebola treatment centers in DRC, including the attack that killed Cameroonian epidemiologist Richard Mouzoko in April in Butembo.   A prosecutor said that militiamen involved in the attacks pointed their fingers—…

Malaria has claimed more than 1,800 lives in Burundi so far this year—roughly the same toll as the yearlong Ebola outbreak in the DRC that has captured global attention.   Cases of malaria have nearly doubled in Burundi this year to 5.7 million, according to a recent UN…

Authorities fighting Ebola are expressing cautious optimism on containing Goma’s outbreak—but steep challenges remain.    By today, all but 5 of 800 contacts of the city’s 3 cases were vaccinated; no additional cases have emerged.   Still, health workers face some suspicion…

A dozen countries across Africa and the Americas are experiencing an alarming uptick in resistance to 2 crucial HIV drugs: efavirenz and nevirapine, according to a WHO report that suggests countries switch to the drug dolutegravir, which is less prone to resistance.

Poor conditions at US border facilities increase the risk of spreading infectious diseases like the flu, physicians warned this morning in a letter urging Congress to investigate the deaths of 6 children in US custody. Noting that flu played a role in at least 3 deaths,…

A year ago today, the WHO confirmed the first 4 Ebola cases in the Democratic Republic of the Congo’s latest outbreak. Back then, hopes were high that a vaccine could squash the outbreak quickly. Experts now say it could drag on for months or years, NPR reports.

Ebola researchers in the Democratic Republic of the Congo have adapted to working in a war zone, Amy Maxmen reports in Nature. A massive vaccination campaign pivoted to deter attacks, researchers are rushing to complete genomic sequencing of virus samples, and an…

An “alarming” decline in the effectiveness of go-to malaria drugs in Southeast Asia could signal their eventual failure across the globe, according to 2 new Lancet studies led by authors from Wellcome Sanger Institute and the

To meet global HIV targets, the world needs to focus on countries falling behind and hard-to-reach populations—including millions affected by humanitarian crises.   Variations on that call to action echoed through coverage of the International AIDS Society Conference on HIV…